文献速递贫血与红细胞疾病

再生障碍性贫血中缺乏HLA的造血干细胞无驱动突变维持克隆性造血

Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
PubMed 文献 · Blood Adv · 2018-01-01

该研究对15例长期缓解(中位13年,范围2-30年)的获得性再生障碍性贫血患者进行HLA阴性粒细胞靶向测序,发现3例高龄患者存在体细胞突变,但仅1例ZRSR2突变与HSPC克隆扩增相关;在6pLOH克隆较大的5例患者中未发现驱动突变,且HLA阴性粒细胞无端粒磨损。

要点

  • 15例长期缓解再障患者中,3例79-92岁患者HLA阴性粒细胞存在体细胞突变(DNMT3A 2例;TET2、ZRSR2、CBL各1例)。
  • 12例27-74岁(中位51.5岁)患者未检测到体细胞突变。
  • 6pLOH克隆较大的5例患者HLA阴性粒细胞全外显子测序未发现驱动突变,且无端粒磨损。

核心结论

  • 逃逸CTL攻击的HLA阴性HSPC克隆基本无髓系恶性肿瘤相关体细胞突变,可在无驱动突变情况下支持长期克隆性造血,除非HLA缺失发生于携带体细胞突变的HSPC。

研究设计与样本

  • 对15例长期缓解(中位13年,范围2-30年)的获得性再生障碍性贫血患者进行HLA阴性粒细胞靶向测序、克隆形成分析及流式荧光原位杂交。
  • 对5例6pLOH克隆较大的患者分选HLA阴性粒细胞进行全外显子测序。

主要发现

  • 3例79-92岁患者HLA阴性粒细胞存在体细胞突变(DNMT3A 2例;TET2、ZRSR2、CBL各1例),12例27-74岁(中位51.5岁)患者未检测到。
  • 3例患者的时序和克隆形成分析显示,仅1例携带DNMT3A突变的HLA阴性HSPC中出现的ZRSR2突变与HSPC克隆扩增相关。
  • 5例6pLOH克隆较大的患者HLA阴性粒细胞全外显子测序未发现驱动突变。
  • 分选HLA阳性和HLA阴性粒细胞的流式荧光原位杂交显示HLA阴性粒细胞无端粒磨损。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clonal hematopoiesis by hematopoietic stem progenitor cells (HSPCs) that lack an HLA class I allele (HLA- HSPCs) is common in patients with acquired aplastic anemia (AA); however, it remains unknown whether the cytotoxic T lymphocyte (CTL) attack that allows for survival of HLA- HSPCs is directed at nonmutated HSPCs or HSPCs with somatic mutations or how escaped HLA- HSPC clones support sustained hematopoiesis. We investigated the presence of somatic mutations in HLA- granulocytes obtained from 15 AA patients in long-term remission (median, 13 years; range, 2-30 years). Targeted sequencing of HLA- granulocytes revealed somatic mutations (DNMT3A, n = 2; TET2, ZRSR2, and CBL, n = 1) in 3 elderly patients between 79 and 92 years of age, but not in 12 other patients aged 27 to 74 years (median, 51.5 years). The chronological and clonogenic analyses of the 3 cases revealed that ZRSR2 mutation in 1 case, which occurred in an HLA- HSPC with a DNMT3A mutation, was the only mutation associated with expansion of the HSPC clone. Whole-exome sequencing of the sorted HLA- granulocytes confirmed the absence of any driver mutations in 5 patients who had a particularly large loss of heterozygosity in chromosome 6p (6pLOH) clone size. Flow-fluorescence in situ hybridization analyses of sorted HLA+ and HLA- granulocytes showed no telomere attrition in HLA- granulocytes. The findings suggest that HLA- HSPC clones that escape CTL attack are essentially free from somatic mutations related to myeloid malignancies and are able to support long-term clonal hematopoiesis without developing driver mutations in AA patients unless HLA loss occurs in HSPCs with somatic mutations.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Imi T, Katagiri T, Hosomichi K, et al. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia. Blood Adv. 2018. PMID: 29720492. doi:10.1182/bloodadvances.2017013953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。